2018 annual financial data
UroGen Pharma 2018 Net margin
Direct answer
Net margin was -6,707.18%.
Operating income was -77,180,000 USD and net income was -75,657,000 USD.
Operating cash flow was -37,334,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,128,000 USD
- Operating income
- -77,180,000 USD
- Net income
- -75,657,000 USD
- Operating cash flow
- -37,334,000 USD